agilon health, inc. Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the agilon health, inc.

Core Viewpoint - A class action lawsuit has been filed against agilon health, inc. for allegedly misleading investors about its business prospects and failing to disclose material industry challenges [1][2]. Group 1: Allegations and Company Performance - The complaint alleges that agilon health, inc. issued unrealistic guidance for 2025, knowing it was unlikely to be achieved due to significant industry headwinds [2]. - The company reportedly overstated the immediate financial benefits from strategic actions taken to mitigate risks [2]. - Following the announcement of disappointing financial results and the resignation of CEO Steven Sell on August 4, 2025, agilon's stock price plummeted over 50%, closing at $0.8801 on August 5, 2025 [3]. Group 2: Class Action Participation - Shareholders interested in serving as lead plaintiffs must submit their papers by March 2, 2026, to represent the class in the litigation [4]. - Shareholders can remain absent class members and still be eligible for recovery without participating in the case [4]. Group 3: Legal Representation - Robbins LLP operates on a contingency fee basis, meaning shareholders incur no fees or expenses unless a recovery is achieved [5].